Dr. Robert Lanza of Advanced Cell Technology Receives Wired Magazine's 2005 Rave Award for Medicine
Related News: Stem Cells and Blindness- Lanza Recognized for Commitment to Finding Cures
WORCESTER, Mass., March 24 /PRNewswire-FirstCall/ -- Dr. Robert Lanza, Vice President of Medical and Scientific Development at Advanced Cell Technology, Inc. (ACTH) has been awarded the 2005 Rave Award for Medicine by Wired Magazine.
Wired Magazine recognized Dr. Lanza's for his commitment to finding cures through stem cell research and his recent work in coaxing stem cells to develop into retinal cells, showing that researchers may look at the transcriptome, or pattern of mRNA expression, to help more quickly identify cells that will mature into specialized tissue. According to Dr. Lanza, the retinal cells that grow could lead to a cure for some forms of blindness...
Dr. Lanza credits his colleagues for their efforts, "This was really a team effort. Special credit should go to Dr. Irina Klimanskaya, who headed our effort to isolate retinal pigment epithelium from stem cells."
In his interview with Wired Magazine, Dr. Lanza commented, "There are 3,000 Americans dying every day from diseases I believe could be treated using stem cell technology." He also cited advice from some of his mentors, including Jonas Salk, B.F. Skinner, and Christiaan Barnard. That advice was to "Make a difference."
William Caldwell, Chief Executive Officer of ACT Holdings, Inc. said, "It is gratifying to see the technology community recognizing the importance of regenerative medicine and the scientists working in the field."
Michael D. West, Chairman, President, and Chief Scientific Officer of Advanced Cell Technology, Inc. commented, "I am very happy for Dr. Lanza's continued recognition in the field of stem cell research. Dr. Lanza has long been and will continue to be an important leader and contributor to our scientific team at Advanced Cell Technology."
Posted on March 25, 2005 05:46 PM